Marshall Wace, LLP Xoma Corp Transaction History

Marshall Wace, LLP

$77.3 Billion
Q3 2024

A detailed history of Marshall Wace, LLP transactions in Xoma Corp stock. As of the latest transaction made, Marshall Wace, LLP holds 14,441 shares of XOMA stock, worth $363,624. This represents 0.0% of its overall portfolio holdings.

Number of Shares

14,441

Holding current value

$363,624

% of portfolio

0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$23.1 - $29.85 $333,587 - $431,063	14,441 New	14,441 $382,000
Q1 2022 May 16, 2022	SELL	$19.62 - $29.61 $129,962 - $196,136	-6,624 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$20.04 - $27.57 $55,751 - $76,699	-2,782 Reduced 29.58%	6,624 $138,000
Q3 2021 Nov 15, 2021	SELL	$23.51 - $34.79 $118,231 - $174,958	-5,029 Reduced 34.84%	9,406 $233,000
Q2 2021 Aug 13, 2021	BUY	$29.0 - $40.64 $2,465 - $3,454	85 Added 0.59%	14,435 $491,000
Q1 2021 May 17, 2021	SELL	$33.21 - $43.99 $50,545 - $66,952	-1,522 Reduced 9.59%	14,350 $586,000
Q4 2020 Feb 16, 2021	SELL	$19.26 - $45.61 $297,875 - $705,404	-15,466 Reduced 49.35%	15,872 $700,000
Q3 2020 Nov 16, 2020	SELL	$16.25 - $20.94 $75,790 - $97,664	-4,664 Reduced 12.95%	31,338 $590,000
Q2 2020 Aug 13, 2020	SELL	$18.45 - $25.51 $144,371 - $199,615	-7,825 Reduced 17.85%	36,002 $711,000
Q1 2020 May 15, 2020	SELL	$15.11 - $28.71 $17,769 - $33,762	-1,176 Reduced 2.61%	43,827 $892,000
Q4 2019 Feb 14, 2020	BUY	$17.5 - $28.66 $787,552 - $1.29 Million	45,003 New	45,003 $1.23 Million
Q3 2019 Nov 14, 2019	SELL	$15.02 - $21.51 $438,358 - $627,769	-29,185 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$11.83 - $18.98 $345,258 - $553,931	29,185 New	29,185 $434,000

Others Institutions Holding XOMA

# of Institutions

Shares Held

6.5M

Call Options Held

100

Put Options Held

1.6K

View Full List

About XOMA Corp

Ticker XOMA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 11,450,800
Market Cap $288M
Description
XOMA Corporation operates as a biotechnology royalty aggregator in Europe, the United States, and the Asia Pacific. The company engages in helping biotech companies for enhancing human health. It acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceutical or biotechnolog...

More about XOMA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Marshall Wace, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Marshall Wace, LLP with notifications on news.

Account